159 related articles for article (PubMed ID: 38356489)
21. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters.
Gupta L; Suku P; Dash A; Bose P; Sharma P; Mallik N; Sreedharanunni S; Varma N; Jandial A; Malhotra P; Sachdeva MUS
Curr Probl Cancer; 2024 Feb; 48():101025. PubMed ID: 37951052
[TBL] [Abstract][Full Text] [Related]
23. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Chng WJ; Van Wier SA; Ahmann GJ; Winkler JM; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Oken MM; Blood E; Henderson K; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Blood; 2005 Sep; 106(6):2156-61. PubMed ID: 15920009
[TBL] [Abstract][Full Text] [Related]
24. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
25. Practical diagnostic approaches to composite plasma cell neoplasm and low grade B-cell lymphoma/clonal infiltrates in the bone marrow.
Hussein S; Gill K; Baer LN; Hoehn D; Mansukhani M; Jobanputra V; Bhagat G; Alobeid B
Hematol Oncol; 2015 Mar; 33(1):31-41. PubMed ID: 24395190
[TBL] [Abstract][Full Text] [Related]
26. FLOCK cluster analysis of plasma cell flow cytometry data predicts bone marrow involvement by plasma cell neoplasia.
Dorfman DM; LaPlante CD; Li B
Leuk Res; 2016 Sep; 48():40-5. PubMed ID: 27479652
[TBL] [Abstract][Full Text] [Related]
27. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
28. Hyperhaploid plasma cell myeloma.
Hoctor VT; Campbell LJ
Cancer Genet; 2012; 205(7-8):414-8. PubMed ID: 22868003
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
[TBL] [Abstract][Full Text] [Related]
30. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
31. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
32. Case report: gastric plasmacytoma resistant to radiation therapy.
Weidenbaum C
Postgrad Med; 2022 Jan; 134(1):122-123. PubMed ID: 34813388
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study.
Zheng W; Liu D; Fan X; Powers L; Goswami M; Hu Y; Lin P; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2013; 84(4):222-8. PubMed ID: 23450831
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
35. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
36. Plasma cell tumours: cytomorphological features in a series of 12 cases diagnosed on fine needle aspiration cytology.
Handa U; Chhabra S; Mohan H
Cytopathology; 2010 Jun; 21(3):186-90. PubMed ID: 19416310
[TBL] [Abstract][Full Text] [Related]
37. Testicular plasmacytoma as presentation of multiple myeloma: case report and review of the literature.
Pow Sang M; Astigueta JC; Abad M; Sánchez J; León J
Arch Esp Urol; 2013 Mar; 66(2):242-8. PubMed ID: 23589604
[TBL] [Abstract][Full Text] [Related]
38. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
[TBL] [Abstract][Full Text] [Related]
39. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.
Rawstron AC; Fenton JA; Ashcroft J; English A; Jones RA; Richards SJ; Pratt G; Owen R; Davies FE; Child JA; Jack AS; Morgan G
Blood; 2000 Dec; 96(12):3880-6. PubMed ID: 11090073
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
